ARIX — Arix Bioscience Share News
0.000.00%
- £183.80m
- £82.85m
- £0.11m
Price Monitoring Extension
Second Price Monitoring Extn
Price Monitoring Extension
Brief: Artios And Merck KGaA Announce Global Strategic Collaboration
Second Price Monitoring Extn
Price Monitoring Extension
Brief: Arix Bioscience Prices Offering In U.S. At $6.00 Per Share
Second Price Monitoring Extn
Price Monitoring Extension
Europe Research Roundup: Anglo American, Glencore, Moncler
Brief: Arix Bioscience Says Atox Bio's Drug Reltecimod Shows Positive Effect On Resolution Of Organ Dysfunction In Phase 3 Accute Trial
Second Price Monitoring Extn
Price Monitoring Extension
Brief: Arix Bioscience Says Amplyx Pharmaceuticals Closed A $53.0 Mln Series C Extension
Brief: Arix Bioscience Says Naseem Amin To Become Executive Chairman
UK Stocks-Factors to watch on March 10 (updated)
UK Stocks-Factors to watch on March 10
Brief: Arix Bioscience Updates On Imara Proposed IPO In The U.S.
Brief: Arix Bioscience Says Imara Inc. Filed For Proposed IPO In The U.S.